PH12015000297B1 - Pharmaceutical combination preparation - Google Patents
Pharmaceutical combination preparationInfo
- Publication number
- PH12015000297B1 PH12015000297B1 PH12015000297A PH12015000297A PH12015000297B1 PH 12015000297 B1 PH12015000297 B1 PH 12015000297B1 PH 12015000297 A PH12015000297 A PH 12015000297A PH 12015000297 A PH12015000297 A PH 12015000297A PH 12015000297 B1 PH12015000297 B1 PH 12015000297B1
- Authority
- PH
- Philippines
- Prior art keywords
- aspirin
- layer
- coating
- clopidogrel
- combination preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Abstract
The present invention relates to a combination preparation containing clopidogrel and aspirin, and to a combination preparation which is stable and has ensured bioavailability, wherein a granule obtained by coating a clopidogrel layer with a protective layer for rapid release and a granule obtained by coating an aspirin layer with an enteric layer are filled in a capsule. The present invention prevents physical contact between clopidogrel and aspirin, which fundamentally prevents the eutectic phenomenon thereof, thereby preventing changes in the content, dissolution behavior, and bioequivalence of a preparation, in the short term, and improving stability thereof, in long term, and preventing damage to the stomach walls by coating aspirin with an enteric layer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150076665A KR101764785B1 (en) | 2015-05-29 | 2015-05-29 | Pharmaceutical combination preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12015000297B1 true PH12015000297B1 (en) | 2018-02-12 |
PH12015000297A1 PH12015000297A1 (en) | 2018-02-12 |
Family
ID=57440503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12015000297A PH12015000297A1 (en) | 2015-05-29 | 2015-09-03 | Pharmaceutical combination preparation |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101764785B1 (en) |
PH (1) | PH12015000297A1 (en) |
WO (1) | WO2016195153A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102055301B1 (en) * | 2018-01-19 | 2019-12-12 | 김한수 | Toothpsate composites typed effervescent and that of manufacturing method |
CN114469962A (en) * | 2021-12-16 | 2022-05-13 | 海口天行健药物研究有限公司 | Preparation method of L-arginine aspirin and L-arginine aspirin capsule |
CN115770229A (en) * | 2022-12-13 | 2023-03-10 | 山东诺明康药物研究院有限公司 | Clopidogrel sulfate aspirin tablet and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101237868A (en) * | 2005-06-13 | 2008-08-06 | 伊兰制药国际有限公司 | Nanoparticulate clopidogrel and aspirin combination formulations |
KR100809903B1 (en) * | 2006-09-05 | 2008-03-06 | 주식회사유한양행 | Stabilized clopidogrel-containing particles, processes for preparing the same, and pharmaceutical compositions comprising the same |
KR100949273B1 (en) * | 2008-02-22 | 2010-03-25 | 한올제약주식회사 | Combined Formulation |
KR101675501B1 (en) | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
WO2013133620A1 (en) * | 2012-03-09 | 2013-09-12 | Yuhan Corporation | Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same |
KR101502588B1 (en) | 2013-05-01 | 2015-03-16 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
-
2015
- 2015-05-29 KR KR1020150076665A patent/KR101764785B1/en active IP Right Grant
- 2015-06-25 WO PCT/KR2015/006466 patent/WO2016195153A1/en active Application Filing
- 2015-09-03 PH PH12015000297A patent/PH12015000297A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20160141314A (en) | 2016-12-08 |
WO2016195153A1 (en) | 2016-12-08 |
KR101764785B1 (en) | 2017-08-07 |
PH12015000297A1 (en) | 2018-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286518A (en) | Capsules and capsule coatings for gastric residence dosage forms | |
PH12016501236A1 (en) | Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine | |
CL2015002148A1 (en) | Pharmaceutical formulations resistant to improper handling | |
ZA201706300B (en) | Capsule for the preparation of infused or soluble beverages | |
PH12016500121A1 (en) | Pharmaceutical tablet comprising acetylsalicyclic acid and clopidogrel | |
PL3313755T3 (en) | Single-dose capsule for the preparation of beverages | |
IN2015DN04161A (en) | ||
PH12015000297B1 (en) | Pharmaceutical combination preparation | |
EP3178473C0 (en) | Acid resistant capsule shell and its preparation process | |
EA201690679A1 (en) | STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN | |
PL3463310T3 (en) | Tablets with high active ingredient content of omega-3 fatty acid amino acid salts | |
PT3060203T (en) | Effervescent tablet containing high level of aspirin | |
DK3641730T3 (en) | Particle and pharmaceutical composition comprising an insoluble dual core shell structure camptothecin compound and process for its preparation | |
PL3102187T3 (en) | Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets | |
DK3368017T3 (en) | Optimized mesalazine containing high dose tablet | |
IL262059A (en) | Film-coated tablet having high chemical stability of active ingredient | |
WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
EA202090913A1 (en) | COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON | |
HK1220113A1 (en) | Pharmaceutical soft gelatin capsule dosage form | |
GB201402457D0 (en) | Capsules containing high doses of phospholipids | |
PH12016501245A1 (en) | Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine | |
EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form | |
FR3027395B1 (en) | COMPOSITION FOR IMMUNO-ENZYMATIC IMMUNOFLUORESCENCE ASSAY AND USES THEREOF | |
PL3328385T3 (en) | Dosage form of vinca alkaloid drug | |
WO2015114655A3 (en) | Modified release tablet of pregabalin |